Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$501K Sell
5,816
-51
-0.9% -$4.55K 0.09% 135
2022
Q2
$535K Sell
5,867
-559
-9% -$49.6K 0.08% 159
2022
Q1
$527K Buy
6,426
+467
+8% +$36.8K 0.07% 167
2021
Q4
$457K Sell
5,959
-9,861
-62% -$785K 0.06% 180
2021
Q3
$1.19M Buy
15,820
+825
+6% +$62.7K 0.12% 130
2021
Q2
$1.17M Buy
14,995
+3,240
+28% +$241K 0.13% 121
2021
Q1
$865K Buy
11,755
+76
+0.7% +$5.61K 0.12% 124
2020
Q4
$912K Buy
11,679
+2,532
+28% +$194K 0.14% 106
2020
Q3
$724K Buy
9,147
+834
+10% +$65.3K 0.14% 104
2020
Q2
$613K Buy
8,313
+226
+3% +$17K 0.13% 115
2020
Q1
$594K Buy
8,087
+2,010
+33% +$158K 0.14% 101
2019
Q4
$527K Sell
6,077
-243
-4% -$20K 0.1% 134
2019
Q3
$504K Sell
6,320
-186
-3% -$14.9K 0.11% 130
2019
Q2
$521K Buy
6,506
+523
+9% +$40K 0.12% 127
2019
Q1
$477K Sell
5,983
-2,080
-26% -$156K 0.11% 125
2018
Q4
$592K Buy
+8,063
New +$569K 0.16% 111

Other funds holding MRK

Kore Private Wealth's MRK Position: Q3 2022 in Review

Kore Private Wealth reduced its Merck (MRK) stake by 0.87% in Q3 2022, selling an estimated $4.55K and leaving 5,816 shares worth $501K. The position accounts for 0.09% of the portfolio, ranked #135.

Kore Private Wealth first reported a position in MRK in Q4 2018 and has held it in 16 quarters since. The position peaked at $1.19M in Q3 2021. 2,990 funds tracked by Wall St. Rank hold MRK as of Q3 2022.

  • Kore Private Wealth held 5,816 shares of Merck worth $501K as of Q3 2022.
  • Kore Private Wealth sold 51 Merck shares in Q3 2022, an estimated $4.55K.
  • Merck made up 0.09% of Kore Private Wealth's portfolio in Q3 2022, its #135 holding.
  • Kore Private Wealth first reported a position in Merck in Q4 2018 and has held it in 16 quarters since.
  • Kore Private Wealth's Merck position peaked at $1.19M in Q3 2021.
  • 2,990 funds tracked by Wall St. Rank held Merck as of Q3 2022.

Based on Kore Private Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.